For patients with non-valvular a-fib
who are seeking an alternative to warfarin, the Watchman Implant offers a potentially life-changing stroke risk treatment option which could free them from the challenges of long-term warfarin therapy.
NSAIDs used currently for 15 to 30 days were associated with higher a-fib
risk relative to "never use.
can show up during an electrocardiogram, or EKG, but because the abnormal rhythm may not occur all the time, people suspected of having the condition usually must wear a Holter monitor for days or weeks to obtain a certain diagnosis.
At present, research on the causes of A-fib
focuses on risk factors such as hypertension, alcohol use, viral infections, pulmonary issues, and others.
Rather than a co-ordinated contraction of the heart muscles, people with A-Fib
encounter a quivering of these muscles.
A 76-year-old white woman with PMH significant for A-fib
(1997), CHF, HTN, DM who was brought to the ER by family with C/O intermittent chest pain, worsening SOB, markedly decreased appetite, weakness, and confusion about 2 or 3 days.
Any one of these risk factors is associated with a 4% annual risk for stroke in a patient with either chronic or paroxysmal A-fib
who is not anticoagulated.
This advanced minimally invasive surgical procedure to correct chronic or intractable A-Fib
is a major step forward in helping patients to overcome this often hard-to-control and potentially life-threatening cardiac disorder.
Keywords: multifactorial approach, alternative therapies, cardiac injury, left atrium, A-Fib
While it could be used to monitor someone who has chronic A-fib
, the app could also detect A-fib
in someone who doesn't know they have it.
Cardiac ablation devices are used to treat a heart rhythm disturbance known as atrial fibrillation, or A-fib
, by destroying the tissue causing the irregularity.
According to two studies, patients with atrial fibrillation treated with catheter ablation are less likely to develop Alzheimer's disease or other forms of dementia, and have a significantly reduced risk of stroke and death compared to A-fib
patients with who are not treated with ablation.
My cardiologist tells me now my heart is in chronic A-fib
In addition to discussing the latest in a-fib
ablation research, this 2011 update covers all the key areas of therapy and patient management, including:
We've been treating A-fib
based on patients' symptoms, duration of arrhythmia and associated co-morbidities.